Aaron Schwartz
@aschwartz.bsky.social
2.9K followers 630 following 450 posts
MD-PhD professing at the University of Pennsylvania. Health, economics, and health economics.
Posts Media Videos Starter Packs
Pinned
aschwartz.bsky.social
Eric Roberts and @joefigs.bsky.social led a groundbreaking new study on Medicaid and Medicare, out today in NEJM. I’m lucky to have been a part of it.

Medicare saves lives. But is it enough to save lives of the most vulnerable Americans? The study suggests no; Medicaid still matters. (1/11)
Loss of Subsidized Drug Coverage and Mortality among Medicare Beneficiaries | NEJM
A total of 14 million Medicare beneficiaries receive the Low-Income Subsidy (LIS), which reduces cost sharing in Medicare Part D. Losing the LIS may impede medication access and affect mortality. U...
www.nejm.org
aschwartz.bsky.social
…ALS patients with the mutation show 6x the T-cell reactivity. The abstract of that paper ends “These findings highlight the potential of therapeutic strategies [for ALS] aimed at enhancing
regulatory T cells” www.nature.com/articles/s41...
www.nature.com
aschwartz.bsky.social
Yentli inherited the c9orf72 mutation that causes ALS from her dad, Frank. Frank, a beloved public school educator, who died last year at 66.

14 years after c9orf72 was discovered as a cause ALS, last week, researchers discovered that T-cells are highly reactive to c9orf72 in ALS patients….
aschwartz.bsky.social
Here is Yentli, one of our MD-PhD students at Penn, speaking powerfully about the stakes here.

Regulatory T-cells could be a key to defeating the genetic mutation that killed her dad with ALS and threatens her life.

From a speech at her high school this week: www.linkedin.com/feed/update/...
aschwartz.bsky.social
It is possible that enhancing the activity of regulatory T-cells, could help treat these diseases or prevent the diseases from progressing.

See, for example, the new study on ALS, highlighting the possible role for treatments aimed at regulatory T cells www.nature.com/articles/s41...
(3/3)
Autoimmune response to C9orf72 protein in amyotrophic lateral sclerosis - Nature
An analysis of T cell responses in people with amyotrophic lateral sclerosis shows that the C9orf72 antigen is a key target of autoimmune responses in the disease, and identifies C9orf72 epitopes that are recognized.
www.nature.com
aschwartz.bsky.social
The past few years have seen several compelling studies linking neurological diseases to infection and our immune responses. For example:

Dementia: Eyting et al, Nature 2025
Multiple sclerosis: Bjornevik et al, Science 2022
ALS: Michaelis et al, Nature (just this week!)
(2/3)
aschwartz.bsky.social
Today's Nobel Prize in Medicine went to the discoverers of regulatory T-cells. How could this discovery about our immune systems change the world?

Here is one possible way: leading to treatments for terrible neurological diseases. (1/3)
Reposted by Aaron Schwartz
mirya.bsky.social
"Full-day kindergarten expansions were responsible for as much as 24 percent of the growth in employment of mothers with kindergartenaged children in this time frame."
aschwartz.bsky.social
Not enough discourse on the Chalamet discount rate
aschwartz.bsky.social
It was very kind of him to open his home to a random college student.

One day, we were talking about his brother, Howard, who won a Nobel for discovering reverse transcriptase. “A lesson: Don’t compare yourself to your brother,” he said. Good advice.
aschwartz.bsky.social
I missed this sad news last month. I first saw Peter Temin’s name when I was a college freshman. It was on a list of people willing to house Swarthmore students over the summer. I lived in his spare bedroom in Cambridge during the summer of 2006, while I was working at a microbio lab…
timobres.bsky.social
Peter Temin, economic historian at MIT, has passed away. He worked both on problems of understanding the past (e.g. "Did Monetary Forces Cause the Great Depression?") and how how the past shapes the present (e.g. "The Vanishing Middle Class.") Terrific scholar and mentor, generous critic.
Reposted by Aaron Schwartz
emilymoin.com
I'm as enthusiastic as anyone else is about effective treatments for Huntington's disease but, for anyone who's curious about the methodology –
aschwartz.bsky.social
The paper that clarified this issue for me is Gelman and Imbens. But i’m not sure that’s what you are looking for. www.nber.org/system/files...
www.nber.org
Reposted by Aaron Schwartz
Reposted by Aaron Schwartz
jasonlschwartz.bsky.social
Open mic picked up someone saying “You’re an idiot!” as ACIP member Retsef Levi was speaking. So things are going great in vaccine policy.
Reposted by Aaron Schwartz
jasonlschwartz.bsky.social
A last-minute surprise vote by ACIP to table indefinitely their vote on removing the HepB birth dose rec. A pleasant surprise (for the time being, at least…)
aschwartz.bsky.social
Yes. If you get vaccinated you are less likely to get hep b and have a test result that confuses you and your doctor.
aschwartz.bsky.social
You are doing the heavy lifting for the surname. I wish your field were more boring these days.
aschwartz.bsky.social
Totally. If I wanted test result interpretation to be so challenging, I would have become a rheumatologist.
aschwartz.bsky.social
With Hepatitis B vaccination under threat, here is one frustrating fact about testing for Hep B. It’s super complicated, based on multiple tests. I’ve often consulted this chart to interpret tests, and occasionally ended up in the dreaded “four interpretations possible” section.
Reposted by Aaron Schwartz
claudia-sahm.bsky.social
""But so long as the President identifies a cause, the determination of “some cause relating to the conduct, ability, fitness, or competence of the officer” is within the President’s unreviewable discretion.""

If the Supreme Court agrees, the Fed is at-will and under control of the President.
annabower.bsky.social
NEW: Trump administration asks SCOTUS to intervene in the Lisa Cook case
In the Supreme Court of the United States
No. 25A
DONALD J. TRUMP, PRESIDENT OF THE UNITED STATES, APPLICANT v.
LISA D. COOK, ET AL.
APPLICATION TO STAY THE PRELIMINARY INJUNCTION
OF THE UNITED STATES DISTRICT COURT
FOR THE DISTRICT OF COLUMBIA AND REQUEST FOR ADMINISTRATIVE STAY
Pursuant to Rule 23 of the Rules of this Court and the All Writs Act, 28 U.S.C.
1651, the Solicitor General-on behalf of applicant Donald J. Trump, President of the United States-respectfully requests that this Court stay the preliminary injunction issued by the U.S. District Court for the District of Columbia (App., infra, 23a) pending appeal to the U.S. Court of Appeals for the D.C. Circuit and any further proceedings in this Court. The Solicitor General also respectfully requests an immediate administrative stay of the preliminary injunction.
This application involves yet another case of improper judicial interference
with the President's removal authority-here, interference with the President's au-
thority to remove members of the Federal Reserve Board of Governors for cause.
The Federal Reserve Act, ch. 6, 38 Stat. 251, broadly authorizes the President
to dismiss members of the Board of Governors "for cause," without further restricting
permissible types of cause. 12 U.S.C. 242. In August 2025, the President determined that cause existed to remove respondent Lisa Cook from the Federal Reserve Board.
(1)
aschwartz.bsky.social
It was covered for patients with diabetes, to test how well their disease was controlled. Not covered for screening people who might have diabetes.